Seborrhoeic Dermatitis
Book chapter (February 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial
Article in Journal of the American Academy of Dermatology (January 2024)
Psychodermatological Disorders in Patients With Primary Psychiatric Conditions: Cross-Sectional Study
Article in JMIR Dermatology (October 2023)